The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

bioinvent.se

Founded Year

1996

Stage

IPO | IPO

Total Raised

$29.66M

Date of IPO

6/12/2001

About BioInvent International

Manufacturer of protein-based drugs. The company offers large-scale contract manufacturing of antibodies and other mammalian cell-derived proteins. Therapeutic- or diagnostic-grade products are produced in a GMP-certified facility based on a continuous perfusion culture system to comply with FDA and EU regulations.

BioInvent International Headquarter Location

Soelvegatan 41

Lund, SE-223 70,

Sweden

46 462868550

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

BioInvent International Patents

BioInvent International has filed 18 patents.

The 3 most popular patent topics include:

  • Clusters of differentiation
  • Immune system
  • Immunology
patents chart

Application Date

Grant Date

Title

Related Topics

Status

2/29/2016

7/16/2019

Molecular biology, Protein domains, Biotechnology, Proteins, Transcription factors

Grant

Application Date

2/29/2016

Grant Date

7/16/2019

Title

Related Topics

Molecular biology, Protein domains, Biotechnology, Proteins, Transcription factors

Status

Grant

Latest BioInvent International News

BioInvent International GAAP EPS of -SEK 1.16, revenue of SEK 16.7M

Apr 27, 2022

BioInvent International GAAP EPS of -SEK 1.16, revenue of SEK 16.7M BioInvent International press release ( OTC:BOVNF ): Q1 GAAP EPS of -SEK 1.16. Revenue of SEK 16.7M (+169.4% Y/Y). Cash flow from operating activities SEK -79.8M. Liquid funds, current and long-term investments as of March 31, 2022: SEK 1,280.9M. To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser. If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.